The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


NovoSeven (400 KIU)



Novo Nordisk A/SEU/1/96/006/007

Main Information

Trade NameNovoSeven (400 KIU)
Active SubstancesEptacog alfa (activated)
Dosage FormPowder and solvent for solution for injection
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/96/006/007

Group Information

ATC CodeB05BA Solutions for parenteral nutrition
B05BA03 carbohydrates

Status

License statusAuthorised
Licence Issued23/02/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back